medline.ch Onkologie Gynäkologische Tumoren

	17Î²-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark. Breast Cancer Res Collin LJ, Woolpert KM, Kjaersgaard A, Ahern TP, Goodman M, McCullough LE, Waller LA, Christensen KB, Damkier P, Hamilton-Dutoit SJ, Lauridsen KL, Christiansen PM, Ejlertsen B, Sørensen HT, Cronin-Fenton DP, Lash TL. PMID: 41469704 [PubMed - as supplied by publisher]
	Breast cancer screening in the Caribbean: a comparative study across six Caribbean Islands with a transatlantic perspective. BMC Public Health Steegmans KEC, Verstraeten S, Hugtenburg JG, Lethongsavarn V, Ponson N, Nuesch D, van Tol E, Libier S, Ljumanovic R, George S, Glaser L, van Kampen S, Gumbs C, Alphonso S, Stürup-Toft S, Browne JL, Schielen PCJI. PMID: 41469615 [PubMed - in process]
	Validation of minimal risk of recurrence classification by the Breast Cancer Index in early stage breast cancer. NPJ Breast Cancer Jilderda MF, Bartlett JMS, Liefers GJ, Zhang Y, Dunn-Davies H, Rebattu V, Salunga R, Meershoek-Klein Kranenbarg E, de Munck L, Hasenburg A, Markopoulos C, Dirix L, van de Velde CJH, Rea D, Anderson AKL, Bastiaannet E, Treuner K, Taylor KJ. PMID: 41469392 [PubMed - as supplied by publisher]
	Discordance of Radiologic and Pathologic Complete Response in Patients with Triple-negative Breast Cancer Undergoing Neoadjuvant Chemotherapy. Acad Radiol Dhungana A, Guo W, Huo D, Nanda R, Kulkarni K, Howard FM. PMID: 41469290 [PubMed - as supplied by publisher]
	Coping Strategies and Perception of Patients With Breast Cancer Post-Surgery in an Underserved Region of Nigeria. Psychooncology Bioku AA, Lu B, Harris P, Sarimiye FO, Jimeta-Tuko JD, Manoj N, Olagunju TO, Kolawole OO, Alqahtani AH, Ostermeyer BK, Olagunju AT. PMID: 41469227 [PubMed - indexed for MEDLINE]
	Radiological Complete Response as a Prognostic Marker in HR-positive Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Implications for Treatment De-escalation. Anticancer Res Goto W, Kashiwagi S, Nishikawa M, Watanabe C, Takada K, Tauchi Y, Ogisawa K, Shibutani M, Kinoshita H, Morisaki T. PMID: 41469135 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Subcutaneous Pertuzumab-Trastuzumab (Phesgo) in Neoadjuvant Treatment of HER2-positive Breast Cancer: Real-world Data from Japan. Anticancer Res Kinoshita H, Kashiwagi S, Nishikawa M, Watanabe C, Takada K, Tauchi Y, Ogisawa K, Shibutani M, Morisaki T. PMID: 41469132 [PubMed - indexed for MEDLINE]
	Risk Factor Analysis for Bevacizumab-induced Severe Hypertension in Advanced Breast Cancer Treatment. Anticancer Res Sugino Y, Sakurada H, Baba M, Saito Y. PMID: 41469130 [PubMed - indexed for MEDLINE]
	Individualized Estimated Glomerular Filtration Rate-based Renal Function Association With Cisplatin Treatment Completion in Cervical Cancer. Anticancer Res Hoshino N, Yoshida K, Kanemitsu Y, Toyama A, Sugiura M. PMID: 41469121 [PubMed - indexed for MEDLINE]
	Efficacy of Magseed Localization for Non-palpable Breast Lesions: A Systematic Review and Meta-analysis. Anticancer Res Al Darwashi LM, Hajeir MY, Abdelrahman RM, Nordahl EJ, Ayesh AR, Ghani A, Alogakos M, Than CA, Nakanishi H, Al Aghbari SA. PMID: 41469115 [PubMed - indexed for MEDLINE]
	Real-world Outcomes of Postoperative Management for Sentinel Lymph Node-positive Breast Cancer Without Intraoperative Assessment: A Single-institution Retrospective Study. Anticancer Res Matsuda H, Goto W, Henmi S, Nishikawa M, Watanabe C, Takada K, Tauchi Y, Ogisawa K, Shibutani M, Kinoshita H, Morisaki T, Kashiwagi S. PMID: 41469114 [PubMed - indexed for MEDLINE]
	Clinical-Genomic Risk Discordance in Early HR+/HER2- Breast Cancer: A Real-World Cohort from Japan Demonstrates Treatment Impact of Oncotype DX. Anticancer Res Henmi S, Kashiwagi S, Matsuda H, Nishikawa M, Watanabe C, Takada K, Tauchi Y, Ogisawa K, Shibutani M, Kinoshita H, Morisaki T. PMID: 41469107 [PubMed - indexed for MEDLINE]
	Protocol for a cervical screening implementation trial comparing two approaches for delivering HPV self-collection in low-resource settings in India: a type 3 hybrid cluster randomised controlled trial (SHE-CAN). BMJ Open Oommen AM, Ashfaq M, Tonsing MV, Cherian AG, Singarayar P, Viswanathan V, Muniswamy V, Hawkes D, Abraham P, Pricilla RA, Manoharan R, Zomawia E, Oldenburg B, Saville M, Krishnaraj K, T S S, Basu P, Brotherton JM, SHE-CAN collaborators. PMID: 41469068 [PubMed - indexed for MEDLINE]
	HPV vaccine awareness and uptake in rural Indigenous communities in Guatemala: a cross-sectional study. BMJ Open Abascal Miguel L, Gaitán Barrillas R, Johnston JS, Ward V, Kraemer Diaz A, Diamond-Smith N. PMID: 41469038 [PubMed - indexed for MEDLINE]
	Feasibility of standard versus fractionated carboplatin-paclitaxel in older adults with ovarian cancer: a retrospective study. Int J Gynecol Cancer Ashton E, Delanoy N, El Gharib R, Rochand A, Gervais C, Nicaise B, Koual M, Azaïs H, Bats AS, Bentivegna E, Fournier L, Gisselbrecht M, Oudard S, Paillaud E, Mebarki S. PMID: 41468824 [PubMed - as supplied by publisher]
	Vulvar Inspection at the Time of Cervical Cancer Screening: European Society of Gynecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Federation for Colposcopy (EFC) Consensus Statements. Obstet Gynecol Surv Preti M, Lewis F, Carcopino X, Bevilacqua F, Burney Ellis L, Halonen P, Hemida R, Jach R, Kesic V, Kyrgiou M, Maggino T, Pedro A, Querleu D, Stockdale C, Taumberger N, Esat Temiz B, Vieira-Baptista P, Gultekin M. PMID: 41468092 [PubMed - indexed for MEDLINE]
	Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial. Obstet Gynecol Surv Post CCB, de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Leary A, Ottevanger PB, McCormack M, Khaw P, D'Amico R, Fyles A, Chargari C, Kitchener HC, Do V, Lissoni A, Procencher D, Genestrie C, Nijman HW, Whitmarsh K, Jürgenliemk-Schulz IM, Feeney A, Lutgens LCHW, Bouma J, Leon-Castillo A, Nout RA, Putter H, Bosse T, Creutzberg CL. PMID: 41468091 [PubMed - indexed for MEDLINE]
	Turning the Tide: Recommendations to Increase Cervical Cancer Screening Among Women Who Are Underscreened. Obstet Gynecol Surv Descamps P, Dixon S, Bosch Jose FX, Kyrgiou M, Monsonego J, Neisingh O, Nguyen L, O'Connor M, Smith JS. PMID: 41468080 [PubMed - indexed for MEDLINE]
	Explainable deep learning for predicting HER-2 expression in breast cancer: a multicenter study. Acta Radiol Lu Z, Hong M, Li X, Yao X, Liu Z, Lin L, Zeng H. PMID: 41468007 [PubMed - as supplied by publisher]
	Organochlorines and breast cancer risk: revisiting evidence through a meta-analytic approach. Int J Environ Health Res Jena P, Pattnayak SP, Panda AK, Prusty BAK, Banerjee BD. PMID: 41467638 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 322418

Seite 1 von 16121

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung